Pronounced Reduction of Cutaneous Langerhans Cell Density in Recently Diagnosed Type 2 Diabetes

Diabetes - United States
doi 10.2337/db13-1444
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Prevalence of Cognitive Impairment in Recently Diagnosed Type 2 Diabetes Patients: Are Chronic Inflammatory Diseases Responsible for Cognitive Decline?

PLoS ONE
Multidisciplinary
2015English

Qualitative Study of Barriers to Clinical Trial Retention in Adults With Recently Diagnosed Type 1 Diabetes

BMJ Open
Medicine
2018English

A Variant of the Glucose Transporter Gene SLC2A2 Modifies the Glycaemic Response to Metformin Therapy in Recently Diagnosed Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Langerhans Cells From Human Cutaneous Squamous Cell Carcinoma Induce Strong Type 1 Immunity

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2012English

Unusual Cutaneous Langerhans Cell Sarcoma Without Extracutaneous Involvement

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2013English

Low Density Lipoprotein (LDL) in Type 2 Diabetes Mellitus

Medical Laboratory Analysis and Sciences Journal
2019English

Association Between Objectively Assessed Sedentary Time and Physical Activity With Metabolic Risk Factors Among People With Recently Diagnosed Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Cost-Effectiveness of Type 2 Diabetes Screening: Results From Recently Published Studies

Gesundheitswesen
MedicineEnvironmentalPublic HealthOccupational Health
2005English

Image Gallery: Cutaneous Langerhans Cell Histiocytosis: A Clinical Masquerade

British Journal of Dermatology
DermatologyMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy